Filing Flows

Filing Flows › Phibro Animal Health (PAHC) › Q4 FY26 › vs Q3 FY26

Phibro Animal Health (PAHC) Q4 FY26 vs Q3 FY26 (quarter over quarter)

Phibro Animal Health's revenue rose $13.2M (+3%) from $384M in Q3 FY26 to $397M in Q4 FY26. The biggest changes: Animal Health +$6.3M (+2%); Mineral Nutrition +$3.6M (+5%); Performance Products +$3.3M (+17%). Gross margin 33.9% against 32.8% (+1.1 pts).

Phibro Animal Health, Q4 FY26: revenue $397M (+5% year over year), operating margin 12.1%, net earnings $21.7M, operating cash flow $24.1M. The chart draws each line against Q3 FY26, the increases inside each band.

Phibro Animal Health: what changed, Q4 FY26 vs Q3 FY26Phibro Animal Health: what changed, Q4 FY26 vs Q3 FY26Working capital & other−$9.3MGross profit$8.7MOperating cash flow$7.9MAnimal Health$6.3MOperating expenses$5.2MCost of revenue$4.5MFree cash flow (OCF − capex)$4.3MMineral Nutrition$3.6MCapital expenditures$3.6MOperating profit$3.5M

Margins

Q4 FY26Q3 FY26Change
Gross margin33.9%32.8%+1.1 pts
Operating margin12.1%11.6%+0.5 pts
Net margin5.5%6.3%-0.8 pts
Free cash flow margin1.3%0.2%+1.1 pts

Every line

LineQ4 FY26Q3 FY26Change%
MFAs and other$208M$206M$1.8M+0.9%
Nutritional Specialties$49.9M$46.8M$3.1M+7%
Vaccines$40.0M$38.6M$1.4M+4%
Animal Health$298M$291M$6.3M+2%
Mineral Nutrition$77.0M$73.4M$3.6M+5%
Performance Products$22.2M$18.9M$3.3M+17%
Revenue$397M$384M$13.2M+3%
Gross profit$134M$126M$8.7M+7%
Cost of revenue$262M$258M$4.5M+2%
Operating profit$48.2M$44.7M$3.5M+8%
Operating expenses$86.2M$81.0M$5.2M+6%
Pre-tax earnings$32.3M$32.3M$28K+0.1%
Other expense, net$15.8M$12.3M$3.5M+28%
Net earnings$21.7M$24.0M−$2.3M-10%
Income tax$10.6M$8.3M$2.3M+28%
Depreciation & amortization$13.3M$12.4M$897K+7%
Share-based compensation$413K$411K$2K+0.5%
Working capital & other$11.4M$20.7M−$9.3M-45%
Operating cash flow$24.1M$16.2M$7.9M+49%
Free cash flow (OCF − capex)$5.2M$890K$4.3M+487%
Capital expenditures$18.9M$15.3M$3.6M+23%

Questions

How much did Phibro Animal Health's revenue grow quarter over quarter in Q4 FY26?

Phibro Animal Health's revenue rose $13.2M (+3%) from $384M in Q3 FY26 to $397M in Q4 FY26.

What drove Phibro Animal Health's revenue change in Q4 FY26?

Animal Health +$6.3M (+2%); Mineral Nutrition +$3.6M (+5%); Performance Products +$3.3M (+17%).

Q4 FY26 results → · Compare in the interactive Sankey →